Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Price-to-Operating-Cash-Flow : (As of Apr. 28, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Price-to-Operating-Cash-Flow?

As of today (2024-04-28), Santhera Pharmaceuticals Holding AG's share price is $11.70. Santhera Pharmaceuticals Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-4.48. Hence, Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Santhera Pharmaceuticals Holding AG's highest Price-to-Operating-Cash-Flow Ratio was 53.28. The lowest was 11.14. And the median was 30.50.

SPHDF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Santhera Pharmaceuticals Holding AG's Cash Flow from Operations per share for the six months ended in Jun. 2023 was $-1.53. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-4.48.

During the past 13 years, Santhera Pharmaceuticals Holding AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.60% per year. The lowest was -69.90% per year. And the median was 19.90% per year.

Santhera Pharmaceuticals Holding AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Price-to-Operating-Cash-Flow Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

48.03

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow falls into.

Santhera Pharmaceuticals Holding AG Price-to-Operating-Cash-Flow Calculation

Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	11.70	/	-4.476
	=

Santhera Pharmaceuticals Holding AG's Share Price of today is $11.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Santhera Pharmaceuticals Holding AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-4.48.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Santhera Pharmaceuticals Holding AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

SANNz:UK SANN:Switzerland

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.